EXPRESSION OF C-KIT RECEPTOR (CD117) AND CD34 IN LEUKEMIC-CELLS

被引:32
|
作者
MUROI, K
NAKAMURA, M
AMEMIYA, Y
SUDA, T
MIURA, Y
机构
[1] Division of Hematology, Department of Medicine, Jichi Medical School, Tochigi-ken
[2] Department of Cell Differentiation, Institute of Molecular Embryology and Genetics, Kunamoto University Medical School, Kumamoto-ken
关键词
C-KIT RECEPTOR; CD34; ACUTE MYELOID LEUKEMIA; ACUTE LYMPHOID LEUKEMIA; CHRONIC MYELOID LEUKEMIA;
D O I
10.3109/10428199509049769
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of c-kit receptor (c-kit R; CD117) and CD34 was examined in acute myeloid leukemia (AML), acute lymphoid leukemia (ALL), chronic myeloid leukemia (CML) in blastic transformation (BT), and myelofibrosis (MF) in myeloid BT. In myeloid leukemia including AML, CML-myeloid BT and MF-myeloid BT, both c-kit R and CD34 were expressed synchronously, while in lymphoid leukemia including ALL and CML-lymphoid BT, only CD34 was highly expressed. A close correlation between c-kit R and CD33 expression and an inverse correlation between c-kit R and CD19 expression were observed when all of the myeloid plus lymphoid leukemia cells were analysed. There was a close correlation between c-kit R and CD34 expression in the myeloid leukemia cells. c-kit R expression may be associated with myeloid phenotypes of leukemic cells and may be useful for the diagnosis of myeloid leukemia. The literature of c-kit R expression in leukemic cells is reviewed here and the comparison of c-kit R and CD34 expression in normal hematopoietic progenitor cells with those on the leukemic counterparts was discussed.
引用
收藏
页码:297 / 305
页数:9
相关论文
共 50 条
  • [1] C-Kit receptor (CD117) in the porcine urinary tract
    Roman Metzger
    Anja Neugebauer
    Udo Rolle
    Levin Böhlig
    Holger Till
    Pediatric Surgery International, 2008, 24 : 67 - 76
  • [2] C-Kit receptor (CD117) in the porcine urinary tract
    Metzger, Roman
    Neugebauer, Anja
    Rolle, Udo
    Boehlig, Levin
    Till, Holger
    PEDIATRIC SURGERY INTERNATIONAL, 2008, 24 (01) : 67 - 76
  • [3] Expression of the stem cell factor receptor c-kit (CD117) in acute leukemias
    Sperling, C
    Schwartz, S
    Buchner, T
    Thiel, E
    Ludwig, WD
    HAEMATOLOGICA, 1997, 82 (05) : 617 - 621
  • [4] CD34/CD117 co-expression in childhood acute leukemia
    Uçkan, D
    Hiçsönmez, G
    Yetgin, S
    Gürgey, A
    Çetin, M
    Karaagaoglu, E
    Okur, H
    Tuncer, AM
    LEUKEMIA RESEARCH, 2000, 24 (03) : 201 - 206
  • [5] C-kit receptor (CD117) expression on myeloblasts and white blood cell counts in acute myeloid leukemia
    Wozniak, J
    Kopec-Szlezak, J
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2004, 58B (01) : 9 - 16
  • [6] c-kit (CD117) Expression in Human Tumors and its Prognostic Value: An Immunohistochemical Analysis
    Medinger, Michael
    Kleinschmidt, Manuela
    Mross, Klaus
    Wehmeyer, Barbara
    Unger, Clemens
    Schaefer, Hans-Eckart
    Weber, Renate
    Azemar, Marc
    PATHOLOGY & ONCOLOGY RESEARCH, 2010, 16 (03) : 295 - 301
  • [7] CD117 (c-kit) Expressiwn on CD34+Cells Participates in the Cytogenetic Response to Imatinib in Patients with Chronic Myeloid Leukemia in the First Chronic Phase
    Dybko, Jaroslaw
    Haus, Olga
    Jazwiec, Bozena
    Urbaniak, Joanna
    Wozniak, Mieczyslaw
    Kaczmar-Dybko, Agnieszka
    Urbaniak-Kujda, Donata
    Kapelko-Slowik, Katarzyna
    Kulickowski, Kazimierz
    ACTA HAEMATOLOGICA, 2014, 132 (02) : 166 - 171
  • [8] Effect of homoharringtonine on bone marrow CD34 plus CD117 plus cells in patients with chronic myelogenous leukemia
    Li, Yu-Feng
    Deng, Zhikui
    Din, Ban-He
    Zhu, Jian-Bin
    LEUKEMIA & LYMPHOMA, 2012, 53 (05) : 934 - 939
  • [9] PLZF-mediated control on c-kit expression in CD34+ cells and early erythropoiesis
    Spinello, I.
    Quaranta, M. T.
    Pasquini, L.
    Pelosi, E.
    Petrucci, E.
    Pagliuca, A.
    Castelli, G.
    Mariani, G.
    Diverio, D.
    Foa, R.
    Testa, U.
    Labbaye, C.
    ONCOGENE, 2009, 28 (23) : 2276 - 2288
  • [10] Expression of the c-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance
    Schwartz, S
    Heinecke, A
    Zimmermann, M
    Creutzig, U
    Schoch, C
    Harbott, J
    Fonatsch, C
    Löffler, H
    Büchner, T
    Ludwig, WD
    Thiel, E
    LEUKEMIA & LYMPHOMA, 1999, 34 (1-2) : 85 - 94